focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Virgin Wines warns sales will be below City forecasts

Thu, 04th May 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Virgin Wines UK PLC - Norwich, England-based online wine retailer - Expects financial year 2023 sales to be slightly lower than market expectations, at around GBP60 million, with underlying pretax profit in the region of GBP500,000 to GBP1 million, with a profitable and cash generative fourth quarter. Thereafter, expects double digit sales growth in financial year 2024, alongside an earnings before interest, tax, depreciation and amortisation margin of around 4% to 5%, as inflationary pressures particularly on freight and glass start to ease. Reports fourth quarter trading is expected to be in line with the previous year, but adds the third quarter was affected by a reduction in order frequency through the WineBank customer membership, a period which saw an increasingly competitive environment. Encouragingly, points out cancellation and conversion rates have started to improve since the end of the first half whilst the trade rate has also recovered from its low point in November 2022.

----------

Pollen Street PLC - London, England-based asset manager - Reports net asset value at March 31 was 900 pence or GBP578 million while its tangible net asset value per share was 540p or GBP347 million. No comparison given. Says assets under management remained at GBP3.4 billion while average fee-paying AUM continued to build to GBP2.5 billion in the first quarter, up from GBP2.3 billion for 2022. Declares a dividend of 16p.

----------

Hansard Global PLC - Isle of Man-based long-term savings provider - Issues trading update for the third quarter to March 31. Says new business was GBP25.4 million, ahead of GBP18.6 million in the previous quarter and down from GBP31.4 million a year prior. Assets under administration were GBP1.12 billion, up GBP15.6 million from the end of December. Continues to make encouraging progress with distribution opportunities for its Japanese proposition, company states. Adds new business in its largest region, Middle East and Africa, rose 20.8%, while in Latin America new business was down 9.5%.

----------

Forward Partners Group PLC - London-based early-stage technology-focused investor - Reports revenue in the year to December 31 of GBP509,000 down from GBP826,000 a year prior with a pretax loss of GBP43.1 million compared to a profit of GBP16.5 million. Net asset value at period end was 72 pence down from 104p a year before. Remains confident that healthy returns can be generated from the investment in early-stage UK startups over the long-term.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Reports pretax loss in the year to January 31 of GBP9.8 million widened from GBP9.5 million a year before on broadly unchanged revenue of GBP475,000 compared to GBP477,000. Basic and diluted earnings per share was 1.54 pence compared to 1.65p. Says well-positioned to advance pipeline of first-in-class preclinical RNAi candidates across multiple therapeutic areas, making significant progress in just one year. Notes increased losses mainly attributable to increased R&D expenditure reflecting further progress and development of its business strategy. Explains company has sufficient funds to continue in operational existence for at least 12 months from the signing of these financial statements.

----------

Let's Explore Group PLC - Manchester, England-based virtual reality entertainment company, formerly called Immotion Group PLC - Reports pretax loss from continuing operations in the year to December 31 of GBP1.9 million widened from GBP1.8 million on reduced revenue of GBP796,000, down from GBP2.5 million. Basic loss per share totalled 0.46 pence compared to 0.43p a year prior. Says group revenue from total operations increased 23% to GBP11.6 million from GBP9.4 million while adjusted earnings before interest, tax, depreciation and amortisation from total operations rose 51% to GBP1.4 million from GBP0.9 million. Notes since the year end the group has sold its largest business, Location Based Entertainment for around USD25 million and a smaller subsidiary, Uvisan.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.